[go: up one dir, main page]

FR2833494B1 - Utilisation de composes de la famille des benzamides comme agent immunosuppresseur - Google Patents

Utilisation de composes de la famille des benzamides comme agent immunosuppresseur

Info

Publication number
FR2833494B1
FR2833494B1 FR0116443A FR0116443A FR2833494B1 FR 2833494 B1 FR2833494 B1 FR 2833494B1 FR 0116443 A FR0116443 A FR 0116443A FR 0116443 A FR0116443 A FR 0116443A FR 2833494 B1 FR2833494 B1 FR 2833494B1
Authority
FR
France
Prior art keywords
immunosuppressant agent
family compounds
benzamide
benzamide family
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0116443A
Other languages
English (en)
Other versions
FR2833494A1 (fr
Inventor
Francois Lang
Delphine Carbonnelle
Jean Yves Petit
Jean Michel Robert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Nantes
Original Assignee
Universite de Nantes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Nantes filed Critical Universite de Nantes
Priority to FR0116443A priority Critical patent/FR2833494B1/fr
Priority to PCT/FR2002/004415 priority patent/WO2003051365A2/fr
Priority to AU2002364456A priority patent/AU2002364456A1/en
Publication of FR2833494A1 publication Critical patent/FR2833494A1/fr
Application granted granted Critical
Publication of FR2833494B1 publication Critical patent/FR2833494B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0116443A 2001-12-19 2001-12-19 Utilisation de composes de la famille des benzamides comme agent immunosuppresseur Expired - Fee Related FR2833494B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0116443A FR2833494B1 (fr) 2001-12-19 2001-12-19 Utilisation de composes de la famille des benzamides comme agent immunosuppresseur
PCT/FR2002/004415 WO2003051365A2 (fr) 2001-12-19 2002-12-18 Utilisation de composes de la famille des benzamides comme agent immunosuppresseur
AU2002364456A AU2002364456A1 (en) 2001-12-19 2002-12-18 Use of compounds of the benzamide family as immunosuppressant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0116443A FR2833494B1 (fr) 2001-12-19 2001-12-19 Utilisation de composes de la famille des benzamides comme agent immunosuppresseur

Publications (2)

Publication Number Publication Date
FR2833494A1 FR2833494A1 (fr) 2003-06-20
FR2833494B1 true FR2833494B1 (fr) 2006-12-15

Family

ID=8870680

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0116443A Expired - Fee Related FR2833494B1 (fr) 2001-12-19 2001-12-19 Utilisation de composes de la famille des benzamides comme agent immunosuppresseur

Country Status (3)

Country Link
AU (1) AU2002364456A1 (fr)
FR (1) FR2833494B1 (fr)
WO (1) WO2003051365A2 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0784462B2 (ja) * 1986-07-25 1995-09-13 日清製粉株式会社 ベンゾイミダゾ−ル誘導体
FR2707085B1 (fr) * 1993-06-30 1995-08-18 Adir Nouveaux dérivés d'alpha amino acides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2720396B1 (fr) * 1994-05-27 1996-06-28 Adir Nouveaux N-pyridyl carboxamides et dérivés leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
FR2833494A1 (fr) 2003-06-20
WO2003051365A3 (fr) 2004-03-04
AU2002364456A1 (en) 2003-06-30
WO2003051365A2 (fr) 2003-06-26
AU2002364456A8 (en) 2003-06-30
WO2003051365A9 (fr) 2004-05-06

Similar Documents

Publication Publication Date Title
DE60217126D1 (de) Herstellung von aminopyrimidinverbindungen
NO20005265L (no) Substituerte benzamider, deres fremstilling og anvendelse som inhibitorer av cystin-proteaser
ID30590A (id) Celana sekali pakai jenis-celana pendek
NO20015855L (no) Ny anvendelse av forbindelser som antibakterielle midler
PL359064A1 (en) Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses
IL157348A0 (en) Benzophenones as inhibitors of reverse transcriptase
GB0013378D0 (en) Use of therapeutic benzamide derivatives
PL358741A1 (en) Utilisation of ketones as precursors of active compounds
PT1600441E (pt) Forma cristalina de cloridrato de lercanidipina para utilização como agente anti-hipertensor
ID26040A (id) Komposisi katalitik yang terdiri dari senyawa titanium, senyawa amina fosfor; pembuatan dan penggunaannya
NO20041968L (no) Anvendelse av cystationin
DE60223962D1 (de) Verwendung Duftstoff zurückhaltender Zusammensetzungen
ITMI20010619A0 (it) Procedimento per la preparazione di schiume poliuretaniche
AU2002338302A1 (en) Bioregulatory combination of active agents
IL176524A0 (en) Ascorbic acid compounds, methods of synthesis and application use thereof
FR2833494B1 (fr) Utilisation de composes de la famille des benzamides comme agent immunosuppresseur
FR2810037B1 (fr) Utilisation de derives de 2-aminothiazoline comme inhibiteurs de no-synthase inductible
AU7402201A (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
EE200300434A (et) Farmatseutiliselt toimivate ühendite kasutamine
GB0101406D0 (en) Characterisation of membranes
FR2823975B1 (fr) Nouvelle utilisation de pyridoindolone
FR2825714B1 (fr) Nouvelle utilisation de complexes d'inclusion de cyclodestrine
ID30381A (id) Penggunaan arilalkanoilpiridazina
AU2001262148A1 (en) Use of 3-iodine-2-propinyl-carbamates as antimicrobial active agent
FR2849595B1 (fr) Utilisation du bocoa prouacensis comme agent amincissant

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20120831